Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-26

FDA Approved: PLERIXAFOR — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original generic application for Plerixafor, enabling Zydus Lifesciences Limited to market the drug in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

ORIG AP for PLERIXAFOR (PLERIXAFOR)